Connect your AI

EXOZ EXOZ Total Current Liabilities

Total Current Liabilities at other companies

GevoGEVO

$26.89M-47.3%

Ginkgo BioworksDNA

$79.6M-31.2%

NAG

Niagen Bioscience, Inc. Common StockNAGE

$22.82M+9.5%

Nature's Sunshine ProductsNATR

$71.37M+0.9%

Opko HealthOPK

$148.38M-49.8%

UpexiUPXI

$70.82M+556%

Other financials

Income statement

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is EXOZ's total current liabilities?: EXOZ (EXOZ) reported total current liabilities of $1.58M in Q1 2026.
How has EXOZ's total current liabilities changed year-over-year?: EXOZ's total current liabilities increased by 9.6% year-over-year, from $1.44M to $1.58M.
What is the long-term trend for EXOZ's total current liabilities?: Over 2 years (2023 to 2025), EXOZ's total current liabilities has grown at a -19.5% compound annual growth rate (CAGR), from $2.42M to $1.57M.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.